These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 445963)

  • 1. Presence of 2,4-diamino-N10-methylpteroic acid after high-dose methotrexate.
    Donehower RC; Hande KR; Drake JC; Chabner BA
    Clin Pharmacol Ther; 1979 Jul; 26(1):63-72. PubMed ID: 445963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of methotrexate and its metabolites 7-hydroxymethotrexate and 2,4-diamino-N10-methylpteroic acid in biological fluids by liquid chromatography with fluorimetric detection.
    Salamoun J; Frantisek J
    J Chromatogr; 1986 May; 378(1):173-81. PubMed ID: 3733970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic assay of methotrexate, 7-hydroxymethortrexate, 4-deoxy-4-amino-N10-methylpteroic acid and sulfamethoxazole in serum, urine and cerebrospinal fluid.
    Cairnes DA; Evans WE
    J Chromatogr; 1982 Aug; 231(1):103-10. PubMed ID: 7119052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic conversion of methotrexate in man.
    Donehower RC
    Recent Results Cancer Res; 1980; 74():37-41. PubMed ID: 7444148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Column liquid chromatography of methotrexate and its metabolites using a post-column photochemical reactor and fluorescence detection.
    Salamoun J; Smrz M; Kiss F; Salamounová A
    J Chromatogr; 1987 Aug; 419():213-23. PubMed ID: 3667779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma methotrexate as determined by liquid chromatography, enzyme-inhibition assay, and radioimmunoassay after high-dose infusion.
    Howell SK; Wang YM; Hosoya R; Sutow WW
    Clin Chem; 1980 May; 26(6):734-7. PubMed ID: 6966194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple preparation of the methotrexate metabolites 7-hydroxymethotrexate and 4-deoxy-4-amino-N10-methylpteroic acid.
    Cairnes DA; Evans WE
    Ther Drug Monit; 1983; 5(3):363-6. PubMed ID: 6636263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid high-pressure liquid chromatographic determination of methotrexate and its metabolites 7-hydroxymethotrexate and 2,4-diamino-N(10)-methylpteroic acid in biological fluids.
    Breithaupt H; Küenzlen E; Goebel G
    Anal Biochem; 1982 Mar; 121(1):103-13. PubMed ID: 7091670
    [No Abstract]   [Full Text] [Related]  

  • 9. Separation and identification of impurities in parenteral methotrexate dosage forms.
    Hignite CE; Shen DD; Azarnoff DL
    Cancer Treat Rep; 1978 Jan; 62(1):13-8. PubMed ID: 626990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,4-Diamino-N10-methylpteroic acid (DAMPA) crystalluria in a patient with osteosarcoma treated with carboxypeptidase-G2 rescue after high-dose methotrexate-induced nephrotoxicity.
    Berga F; Luna P; Martorell C; Rey J; Gomila I; Gimenez S; Costa-Bauza A; Elorza MÁ; Sánchez I; Grases F; Barceló B
    Clin Chim Acta; 2018 Dec; 487():1-5. PubMed ID: 30205081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and quantitation of methotrexate and methotrexate metabolites in clinical high-dose therapy by high pressure liquid chromatography and field desorption mass spectrometry.
    Przybylski M; Preiss J; Dennebaum R; Fischer J
    Biomed Mass Spectrom; 1982 Jan; 9(1):22-32. PubMed ID: 7037062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of 4-amino-4-deoxy-N10-methylpteroic acid with the radioimmunoassay of methotrexate.
    Paxton JW
    Clin Chem; 1979 Mar; 25(3):491-2. PubMed ID: 262195
    [No Abstract]   [Full Text] [Related]  

  • 13. Dihydrofolate reductase enzyme inhibition assay for plasma methotrexate determination using a 96-well microplate reader.
    Widemann BC; Balis FM; Adamson PC
    Clin Chem; 1999 Feb; 45(2):223-8. PubMed ID: 9931044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.
    Widemann BC; Sung E; Anderson L; Salzer WL; Balis FM; Monitjo KS; McCully C; Hawkins M; Adamson PC
    J Pharmacol Exp Ther; 2000 Sep; 294(3):894-901. PubMed ID: 10945838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination.
    Klapkova E; Kukacka J; Kotaska K; Suchanska I; Urinovska R; Prusa R
    Clin Lab; 2011; 57(7-8):599-606. PubMed ID: 21888024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.
    Breithaupt H; Küenzlen E
    Cancer Treat Rep; 1982 Sep; 66(9):1733-41. PubMed ID: 6956440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine and ornithine analogues of methotrexate as inhibitors of dihydrofolate reductase.
    Kempton RJ; Black AM; Anstead GM; Kumar AA; Blankenship DT; Freisheim JH
    J Med Chem; 1982 Apr; 25(4):475-7. PubMed ID: 7069726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of antifolate activity in skin of rats following systemic administration of methotrexate.
    Zimmerman CL; Franz TJ; Slattery JT
    J Invest Dermatol; 1984 Jan; 82(1):57-61. PubMed ID: 6690631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence and significance of D-methotrexate as a contaminant of commercial methotrexate.
    Cramer SM; Schornagel JH; Kalghatgi KK; Bertino JR; Horváth C
    Cancer Res; 1984 May; 44(5):1843-6. PubMed ID: 6713386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of 4-amino-4-deoxy-N10-methylpteroic acid and methotrexate transport by mouse leukemia cells.
    Kessel D
    Mol Pharmacol; 1969 Jan; 5(1):21-5. PubMed ID: 5392912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.